CLINICAL_TRIALS trial_result · 2018-02-15

Clinical Trial Update: Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]

Summary

Phase 2 clinical trial evaluating dasatinib for chronic lymphocytic leukemia (refractory and various stages) has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-02-15